HAEMOPHILIA A WITH INHIBITORS
Clinical trials for HAEMOPHILIA A WITH INHIBITORS explained in plain language.
Never miss a new study
Get alerted when new HAEMOPHILIA A WITH INHIBITORS trials appear
Sign up with your email to follow new studies for HAEMOPHILIA A WITH INHIBITORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New weekly or monthly injection could transform bleeding disorder treatment
Disease control CompletedThis study tested Mim8, a new medication designed to prevent bleeding episodes in people with hemophilia A, including those with or without inhibitors. Participants received Mim8 injections either once a week or once a month and were compared to their previous treatments. The goa…
Matched conditions: HAEMOPHILIA A WITH INHIBITORS
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Apr 02, 2026 14:58 UTC
-
New hemophilia drug Mim8 tested for safe switch from current treatment
Disease control CompletedThis study checked if it was safe for people with hemophilia A to switch from their current preventive medicine, emicizumab, to a new one called Mim8. It involved 61 adults and adolescents who had been on emicizumab. Participants received Mim8 via a pen injector weekly, every two…
Matched conditions: HAEMOPHILIA A WITH INHIBITORS
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC